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Abstract 
SARS-CoV-2, the etiological agent of the COVID-19 pandemic, has rapidly become a 
worldwide public health concern. Classified as a betacoronavirus, it is the third human 
coronavirus (HCoV) to emerge in the 21st century that causes severe disease, alongside SARS-
CoV and MERS-CoV. The genome consists of open reading frames encoding accessory proteins 
and four structural proteins, including the spike protein which is a key determinant of host cell 
tropism. Mutations within the genome, particularly the spike gene, have been linked in-vitro to 
increased binding affinity to the human receptor angiotensin-converting enzyme 2 (hACE2), 
increased fitness in human hosts, and immune evasion. Here, both previously studied and novel 
mutations were correlated with an increase in case and death rates in California, U.S.A. Eleven 
mutations, occurring both within nonstructural proteins as well as the spike protein, were found 
to correlate with significantly increased deaths, while one mutation in the open reading frame 3a 
(ORF3a) gene correlated with both increased cases and death rates. 
Introduction 
In late December 2019, clusters of pneumonia patients began to emerge in Wuhan, China, 
centered around wet seafood markets. A novel coronavirus, initially named 2019-nCoV, was 
determined to be the etiological agent of the disease (Zhu et al., 2020). In March 2020, it was 
officially designated as SARS-CoV-2 by the International Committee on Taxonomy of Viruses 
(Zhu et al., 2020). The virus has spread throughout the world, and as of the time of writing, has 
resulted in over 265 million infections and 5.2 million deaths according to the World Health 
Organization Coronavirus COVID-19 Dashboard, with a mortality rate of about 2%. It is the 
seventh coronavirus discovered to be capable of infecting humans (HCoVs) and is classified as a 
betacoronavirus (Zhu et al., 2020). Coronaviruses, named for their crown – or corona –
appearance when viewed under electron microscopy, are single-stranded positive-strand RNA 
viruses with a typical genome length of around 30kb, making coronavirus genomes the largest of 
all RNA viruses (Lee et al., 1991; R. & Sonia, 2005). Typical betacoronavirus genomes consist 
of a 5’ untranslated region (UTR), open reading frames encoding nonstructural accessory 
proteins, spike (S), envelope (E), membrane (M), nucleocapsid (N), and a 3’ UTR (Zhu et al., 
2020). The spike protein is a key determinant of host tropism (Kang et al., 2021), and is 
comprised of two subunits. The S1 subunit contains a receptor-binding domain (RBD) which 
recognizes and binds with the receptor, and S2 mediates membrane fusion (Korber et al., 2020). 
HCoVs are ubiquitous in society; four viruses circulate as the common cause of the 
common cold. The first HCoV was isolated in 1965 from common cold patients (Tyrell & 
Bynoe, 1965), and one year later was classified as HCoV-229E (Hamre & Procknow, 1966). 
Soon afterward, HCoV-OC43 was isolated from patients experiencing similar symptoms as 
HCoV-229E. However, they were found to have no serological cross-reactivity (McIntosh et al., 
1967), suggesting that each virus has distinct surface proteins and therefore unique evolutionary 
pathways. HCoV-HKU1, which emerged in 2005, has rapidly spread across the globe and 
similarly produces mild symptoms (Woo et al., 2005). HCoV-NL63 typically induces minor 
symptoms in immunocompetent patients and can cause severe respiratory illness in young 
children and immunocompromised individuals (Ebihara et al., 2005). Coronaviruses have been 
found to proliferate in animals such as bats, which act as reservoirs for the virus. Recombination 
of viruses is typical in these hosts, giving rise to novel viruses (Su et al., 2016). 
 In 2002, the world faced a new degree of coronavirus threat, as clusters of deadly 
pneumonia emerged in China, with the disease later labeled severe acute respiratory syndrome 
(SARS). A novel HCoV was soon discovered to be the causative agent of the disease and was 
classified SARS-CoV (Peiris et al., 2003). After plaguing the world for months, the virus 
vanished, with 8098 recorded probable cases and leaving almost 10% of those patients dead 
(Stadler et al., 2003). SARS-CoV is believed to have arisen from spillover events of SARS-
related (SARSr) coronaviruses that typically circulate in bats. SARSr-Rh-BatCoV, a genetically 
similar virus, was discovered to circulate in high levels in Chinese horseshoe bats in the region 
where SARS-CoV emerged. Given the genetic identity, it is likely that horseshoe bats act as the 
reservoir for SARS-CoV-like viruses, while other species capable of being infected with SARSr-
CoVs, such as civets, are the intermediate hosts (Lau et al., 2010). Ten years later, in 2012, 
another deadly coronavirus emerged: the Middle Eastern respiratory syndrome virus, MERS-
CoV, which spreads in small clusters throughout the world, never reaching sustained community 
transmission (Raj et al., 2014). Compared to other HCoVs, MERS-CoV has an astonishingly 
deadly; as of 2017, there were 2040 confirmed cases and 712 deaths; a mortality rate of ~35% 
(Chafekar & Fielding, 2018). The virus’s natural reservoir has been discovered to be camels – in 
2015, a novel MERS-CoV lineage showing high levels of recombination was traced back to the 
animal (Su et al., 2016).  
 Much debate has occurred surrounding the origins of SARS-CoV-2. In January 2020, 
excess pneumonia deaths were localized around the Wuhan markets, rather than other 
hypothesized sources such as the Wuhan Institute of Virology. This suggests that the source of 
the virus was the markets themselves (Holmes et al., 2021). Like SARS-CoV, SARS-CoV-2 
shows a high degree of nucleotide identity with bat viruses. Bat CoV RaTG13, which was 
isolated in 2013, shares 96% identity, including a 97% amino acid identity of the spike protein 
(Kang et al., 2021). SARSr-CoVs bat-SL-CoVZC45 and bat-SL-CoVZCX21, isolated in 2018, 
share an 88% identity (Lu et al., 2020). However, due to the geographical distance between the 
Wuhan markets and the source of these isolates, it is probable that like SARS-CoV, SARS-CoV-
2 had an intermediate host that increased fitness for human hosts. Pangolins, which were present 
at the markets, have been proposed as that intermediate host: pangolin SARSr-CoVs have been 
found that have a ~97.4% amino acid identity of the spike protein (Kang et al., 2021). SARS-
CoV-2, SARS-CoV, and MERS-CoV likely share a common ancestor, as the newer virus shares 
a 79% identity to SARS-CoV and a 50% identity to MERS-CoV (Lu et al., 2020). 
 Nucleotide mutational rate is relatively consistent across the three deadly HCoVs. Across 
all CoVs, there is an average mutational rate of ~10-4 per year per site (Pyrc et al., 2006). SARS-
CoV’s mutational rate lies between 0.80-2.38x10-3 per year per site (Zhao et al., 2004), while 
MERS-CoV’s rate is estimated to be 1.12x10-3 per year per site (Cotten et al., 2014), and SARS-
CoV-2’s is estimated to be ~1.8x10-3 per year per site (Li et al., 2020). The SARS-CoV-2 spike 
protein has a higher rate of mutation when compared to the rest of the genome. On a per 
replication basis, the entire genome has a rate of 1.25x10-6 mutations per site, while the S region 
has a rate one magnitude higher of 1.6x10-5 mutations per site per replication (Amicone et al., 
2021). The increased mutational rate of the S region likely confers an advantage to SARS-CoV-2 
as it adjusts to human cells. Early selective sweeps within the S region of the genome have been 
hypothesized to have contributed to the zoonotic leap from the intermediate host to humans, 
including mutations T372A (Kang et al., 2021) and D614G (Holmes et al., 2021) that were both 
found to vastly increase human cellular binding efficiency. Despite key mutations, both SARS-
CoV-2 and SARS-CoV have similar spike RBDs, and utilize human angiotensin-converting 
enzyme 2 (hACE2) as their cellular receptors (Lu et al., 2020). 
 Given SARS-CoV-2’s novelty to humans, it is expected that the virus will change as it 
adapts to its new host. Improvements to viral fitness will ultimately present themselves as 
changes in infectivity and mortality, measured via case and death rates. In this study, isolates 
from California, U.S.A. will be analyzed to determine mutations that may affect viral fitness. 
Mutations that occur within key regions of the SARS-CoV-2 genome that affect cell entry and 
replication, such as the spike, are hypothesized to increase both case and death rates.  
 
Methodology 
Genomes isolated from samples in California, U.S.A. were downloaded from the 
National Library of Medicine National Center for Biotechnology Information (NCBI) SARS-
CoV-2 resources hub for collection dates between January 2020 and February 2021. Sample 
density ranged from 7 (January 2020) to 3600 (January 2021). Monthly case and death rates were 
downloaded from the COVID-19 Data Repository by the Center of Systems Science and 
Engineering at Johns Hopkins University, and extracted utilizing a homebrew python script 
extractData.py. Wtdbg2 assembler was utilized to create consensus sequences for each month. 
Samples were then assembled into a master consensus sequence to which each month’s 
consensus sequence was aligned, utilizing MAFFT version 7 (Katoh & Standley, 2013). 
CodonCode Aligner version 9.0.2 (CodonCode, Dedham, MA) was utilized to parse samples for 
mutations, which were then exported to Excel. Genotypes with a mutation that appears in more 
than two months’ consensus sequences were analyzed. Workflow performed again, on a weekly 
instead of a monthly basis. Genomes isolated from California, U.S.A. were downloaded from the 
NCBI from the week beginning 04/01/2020 to 03/30/2021, producing 52 weekly consensus 
sequences. Python script extractDataWeekly.py utilized to extract weekly case and death data. 
Final sequences were aligned with the publicly available reference genome MN90847 published 
by Ensembl on the European Nucleotide Archive (EMBL-EBI, Hinxton, Cambridgeshire, UK) 
utilizing EMBOSS Stretcher (Myers & Miller, 1988). To analyze structural differences between 
selected mutants, Phyre2 was utilized for .pbd generation and structure predictions (Kelley et al., 
2015). Molecular graphics and analyses were performed using UCSF Chimera from the 
Resource for Biocomputing, Visualization, and Informatics and the University of California, San 
Francisco (Pettersen et al., 2004). 
 
Results and Discussion 
Monthly Analysis 
One point mutation was found to correlate with significantly increased case and death 
rates, while another point mutation was found to correlate with increased death, but not case, 
rates. G25563T correlated with increased case rates (p=0.011) and death rates (p=0.018); while 
T27890G correlated with increased death rates (p=0.031) but not case rates (p=0.31). Other point 
mutations that were present in multiple month’s consensus sequences but found to not 
significantly correlate with neither case nor death rates were T1054C and G20263A. Complete 
data can be found in California Data.xlsx. 
Weekly Analysis 
One point mutation, G25563T (p=0.022) was found to correlate with significantly 
increased case rates, while 10 mutations correlated with significantly increased death rates: 
C1059T (p=0.0002), C2395T (p=0.005), thymine insertion at 12102 (p=0.0388), G17014T 
(p=0.00004), G21600T (p=0.0001), G22018T (p=0.0007), T22917G (p=0.0001), G25563 
(p=0.000186), C26681T (p=0.000007), C29362T (p=0.000002). Three mutants were discovered 
that appeared in fall 2020-early winter 2021, that correlated with less deaths than the wild-type 
that reappeared later: A20268G (p=0.0017), A28272T (p=0.00008), C28854T (p=0.0021). 
Around 150 other mutations were found to not significantly correlate with increased case 
or death rates. Complete data can be found in California Correlation Weekly.xlsx. 
Figure 1. Selected genomic isoforms and their average weekly deaths 
Genome 
Mutation 
Amino Acid Mutation Protein Predicted Structure Change(s) 
C1059T T84I Nsp2 β-sheets change to α-helices around 
residues 100 and 120. 
C2395T Synonymous mutant Nsp2 None 
12102T 
(insertion) 
AIA > L-P Nsp8 Loss of N-terminal α-helix 
G17014T D10Y Nsp13 helicase 
domain 
C-terminal shift of α-helix around 
residue 10; shortening of α-helix 
around residue 110 
G21600T S13I S Inward folding of β-sheets around 
residue 680; loss of α-helix around 
residue 250 
G22018T W152C S Loss of α-helix around residue 250 
T22917G L452R S Hydrophobicity change in RBD 
G25563T Q57H ORF3a Hydrophobicity change around H57 
C26681T Synonymous mutant M None 
T27890G n/a n/a n/a (Occurs in noncoding region) 
C29362T Synonymous mutant N None 
Table 1. Selected mutations and their effect on SARS-CoV-2 proteins. 
Stabilizing mutation of ORF3a may convey increased pathogenicity to SARS-CoV-2 
Single nucleotide polymorphism G25563T was correlated with significantly increased 
cases and deaths. This nucleotide occurs in position 171 of the open reading frame 3a (ORF3a) 
segment of the genome, resulting in a nonsynonymous mutation of amino acid 57 from 
glutamine to histidine (Q57H). ORF3a encodes a 275 amino acid, six-subunit protein consisting 
of three transmembrane domains and an intracellular cytoplasmic domain, localized to the region 
of the cell containing the Golgi apparatus (Padhan et al., 2007; Kern et al., 2021). ORF3a’s 
function and pathogenicity have been widely studied, primarily through its SARS-CoV analog. 
However, its precise mechanism of action is unknown. One transmembrane domain contains a 
potassium-sensitive ion channel that is believed to promote virus release, and inhibition of this 
domain using siRNA lead to significantly decreased 
viral load (Lu et al., 2006). The intracellular domain of 
ORF3a has been shown to contain binding sites for 
caveolin proteins, which contribute to the formation of 
caveolae, membrane microdomains that are responsible 
for the intake of small molecules and play a role in viral 
entry. Specifically, caveolin-1 has been shown to 
regulate extracellularly regulated kinase (ERK) and 
inducible nitric oxide synthase (iNOS), which are 
involved in the cellular response to viral infection 
(Padhan et al., 2007). Through this second mechanism, 
ORF3a inhibiting caveolin-1 action may interfere with cellular defence processes. ORF3a has 
been implicated in pro-apoptotic pathways, inducing apoptosis through cleavage and activation 
of caspase-8. Interestingly, this mechanism in SARS-CoV-2 is significantly weaker than in 
SARS-CoV (Ren et al., 2020). This suggests that the mutations in the ORF3a are responsible for 
the decreased mortality of the newer virus when compared to its relative, and may play a role in 
the high rate of asymptomatic infection. Along with proapoptotic activity, ORF3a promotes a 
cytokine response to infection through activation of inflammatory mediators C-Jun N-terminal 
kinase (JNK), nuclear factor kappa B (NF-κB), and interleukin 8 (IL-8) promoters (Kanzawa et 
al., 2006). It additionally has been shown to activate pro-IL-1β gene transcription (Siu et al., 
Figure 2. ORF3a protein, highlighting residue 57 
with molecule depiction 
 (wild-type, top; mutant, bottom) 
2019). The pro-inflammatory action of ORF3a likely contributes to hyper-inflammation and 
cytokine storm, a key cause of COVID-19 mortality (Mehta et al., 2020).  
 Amino acid 57 occurs in the center of the ORF3a protein, near the central pore and lower 
tunnel segments. In wild-type SARS-CoV-2, amino acid 57 occurs as the uncharged polar amino 
acid glutamine, while the mutation to histidine causes this residue to become charged. This 
ultimately results in the surface becoming more hydrophobic with a minor change to surface 
geometry. Two separate studies, by Hassan et al. (2021) and Bianchi et al. (2021) have utilized 
simulation software Meta-SNP and DynaMut, respectively, to show that this mutation conveys a 
stabilizing effect to the protein and likely increases pathogenicity. Stabilization of ORF3a may 
potentiate the pathogenic effects outlined above, ultimately leading to the observed increase in 
infections and deaths where the Q57H mutation is dominant. 
Nonstructural protein 2 (nsp2) may promote a pro-viral cell environment  
Mutation of cytosine to thymine at base 1059 within the open reading frame 1ab 
(ORF1ab) region correlates with an increased rate of death. ORF1ab is a polyprotein sequence 
consisting of overlapping reading frames a and ab, encoding 16 nonstructural proteins. C1059T 
is a nonsynonymous mutation occurring in nonstructural protein 2 (nsp2), resulting in the 
Figure 3. Hydrophobicity surface of SARS-CoV-2-ORF3a, zoomed on residue 57 
 (wild-type, left; Q57H, right. Blue, hydrophilic; red, hydrophobic) 
 
conversion of the polar uncharged amino acid 
threonine to the nonpolar uncharged residue 
serine (T84I).  
Nsp2 has a wide range of hypothesized 
effects, ranging from affecting mitochondria 
biogenesis to inhibiting apoptosis, and its 
sequence varies greatly between HCoVs (Davies 
et al., 2020). The SARS-CoV nsp2 analog has been found to form complexes with at least 11 
host proteins in HEK293 cells. The strongest interactions are with cellular signaling proteins 
prohibitin 1 and 2 (PHB1/PHB2), which localize to both the mitochondrial inner membrane and 
nucleus (Tatsuta et al., 2005; T. et al., 2009). PHB1 and PHB2 are believed to play a role in the 
cell cycle shift from G1 to S phase, conveying anti-proliferative effects. Their mechanism of 
action appears to be in the repression of E2F, a family of transcription factors that consists of 
both cell cycle progression activators and repressors (Wang et al., 1999). Overexpression of 
activator factors in the E2F family has been shown to cause cells to reenter S phase despite the 
presence of other signals for cycle arrest (Dimova & Dyson, 2005). Therefore, if the interaction 
of nsp2 and prohibitins is repressive, E2F repression may be reduced. While this would not 
necessarily result in overexpression of activator E2F factors, reduced repression may result in 
similar effects including the upregulation of S phase cell machinery, an optimal outcome for 
SARS-CoV-2 which relies on this machinery for its replication. Nsp2 may similarly promote a 
welcoming cell environment through interactions with stomatin-like protein 2 (STOML2), a 
mitochondrial regulator. Increased STOML2 levels within a cell have been linked to increased 
ATP production and inhibition of apoptosis pathways, both beneficial for viral replication (A. et 
 Figure 4. Nonstructural Protein 2, highlighting residue 
84 with molecule depiction 
 (wild-type, left; mutant, right) 
al., 2011). Nsp2 may potentiate these effects of STOML2, further promoting a pro-viral 
environment. 
Nonstructural protein 8 (nsp8) enhances RNA polymerase activity 
Thymine insertion at position 12102 occurs in the 
ORF1ab segment of the genome, at base pair 11 of the 
segment encoding nonstructural protein 8 (nsp8), a golf 
club-shaped accessory protein. This results in the first three 
codons translating to N-STOP-P instead of AIA, 
shortening the polypeptide by two residues. Nsp8 appears 
to assist in viral genome replication, as it was found to 
form a complex with nsp7 and nsp12, a catalytic accessory 
protein containing an RNA-dependent RNA polymerase 
domain (RdRp) (Ahn et al., 2012). This complex is 
responsible for replicating the viral genome within the host cell, and the subunits are relatively 
well-conserved between SARS-CoV-2 and SARS-CoV. Two copies of Nsp8 form “sliding 
poles” along the RNA’s path of egress from the complex, assisting in preventing the dissociation 
of the newly formed genome from the polymerase (Hillen et al., 2020). This segment has an 
internal diameter of about 30Å, with the N-terminal domain (NTD) – consisting of two α-helices 
– on the outer edge of the complex (Zhai et al., 2005). Both nsp7 and nsp8 are essential to 
nsp12’s RdRp function, enhancing its activity (Subissi et al., 2014). While the entire complex is 
relatively highly conserved between the two HCoVs, SARS-CoV-2’s polymerase complex is 
significantly less efficient and stable than its SARS-CoV relative, operating at about a 35% 
relative efficiency (Peng et al., 2020). There are myriad reasons behind this difference, including 
Figure 5. Nonstructural Protein 8 
 (mutant, left; wild-type, right. 
Difference highlighted in red) 
that the machinery is likely optimized for the virus’s natural reservoir and functions just 
sufficiently enough for human pathogenicity; as the virus evolves, one could expect the 
complex’s efficiency and stability to increase. Interestingly, substituting SARS-CoV’s nsp8 
analog into the complex boosted its efficiency by 2.1 times, highlighting this accessory protein’s 
importance in the infection process (Peng et al., 2020). Nsp8 has also been found to interact with 
the ORF6 protein in SARS-CoV, and while their exact interaction is unknown, ORF6 itself has 
been implicated in coronavirus lethality (Pewe et al., 2005). Given this mutation’s correlation 
with increased death rates, it is likely that the subsequent structural change in nsp8 increases the 
polymerase’s efficiency and may potentiate ORF6’s lethal effects. 
Nonstructural protein 13 (nsp13) interacts with the SARS-CoV-2 RdRp Holoenzyme 
SARS-CoV-2 nonstructural protein 
13 (nsp13) is a ~67kDa accessory 
protein encoded within the 
ORF1ab polyprotein sequence 
(Tanner et al., 2003). It consists of 
four distinct domains: an N-
terminal zinc-binding domain 
(ZBD), a helical “stalk” domain, a 
β-barrel, and a helicase domain 
(Newman et al., 2021). Mutation of G to T at nucleotide 17014 has been correlated with higher 
death rates and results in the transformation of helicase residue D10 to Y (D10Y). In SARS-
CoV, whose nsp13 analog differs by only one amino acid (Newman et al., 2021), nsp13 
functions as a helicase, unwinding approximately 280bp per second; it was found to interact with 
Figure 6. Nonstructural Protein 13 Helicase Domain, highlighting residue 10 
with molecule depiction 
 (wild-type, left; mutant, right) 
the RdRp domain of nsp12, which doubles the unwinding rate (Adedeji et al., 2012; Jia et al., 
2019). This helicase action occurs exclusively in the 5’ to 3’ direction (Shu et al., 2020). Nsp13 
additionally has nucleotide triphosphate (NTP)-ase activity, showing a preference for ATP and 
GTP (Shu et al., 2020). Nsp13 interacts strongly with the entire SARS-CoV-2 replication-
transcription complex (RTC) of nsp7, nsp8, and nsp12 (RdRp holoenzyme), forming the 
complex nsp13-RTC. While nsp13 helicase translocation occurs in the 5’-3’ direction, RdRp 
translocation occurs 3’-5’. This indicates that nsp13’s primary role is in a process referred to as 
backtracking, where the RTC slides backward on the nucleic acid (Chen et al., 2020). 
Backtracking has numerous functions, notably including maintaining genomic fidelity through 
proofreading and the processing of sub-genomic RNA transcripts (Nudler, 2012). Proofreading 
in SARS-CoV-2 involves the nsp10-nsp14 complex, which contains an N-terminal exonuclease 
(ExoN) domain that is normally unable to access the nucleotide buried in the RdRp active site 
(Subissi et al., 2014). Backtracking causes the nsp13 helicase to translocate the RNA strand 
backward, resulting in the erroneous single-stranded 3’ RNA to be moved out of the RdRp active 
site and into the NTPase active site, allowing it to be accessed by other enzymes such as the 
nsp10-nsp14 complex (Malone et al., 2021). Backtracking additionally confers protection against 
mutagenic antivirals, such as remdesivir, and has been widely studied in HCoVs (Smith et al., 
2013). This process evolved independently in both RdRp and DNA-dependent RNA polymerase 
(DdRp), highlighting its importance in replication and transcription (Malone et al., 2021).  
 Nsp13 additionally has been found to promote a pro-viral environment through the 
inhibition of interferon and NF-κB. It has been found to associate with TBK1, a regulatory 
kinase that is involved in IRF3 and NF-κB signaling pathways; phosphorylated TBK1 and IRF3 
were found to exist in lower levels in cells with nsp13 overexpression (Vazquez et al., 2021). 
Additionally, it was found to inhibit IFN-β promoter activity (Lei et al., 2020). These effects 
appear to act counter to the pro-inflammatory action of the ORF3a protein discussed above. 
Given nsp13’s key role in replication fidelity, transcription, and cell defense mechanism 
disruption, it is being actively investigated as an antiviral target. 
Spike (S) is a Key Determinant of Cellular Tropism, Infectivity, and Immune Response 
The S protein of CoVs is perhaps the most widely studied of all CoV proteins, rightfully 
so. S, colloquially known as the spike 
protein, is a ~200kDa protein 
consisting of an extracellular N-
terminal end, a transmembrane 
domain, and an intracellular C-
terminal end (Bosch et al., 2003). S 
exists as homotrimers on the surface 
of the SARS-CoV-2 virion and is a 
viral fusion protein that mediates host 
cell attachment and fusion of the cell-
virion membranes (Huang et al., 
2020) (Jan et al., 2003). The S protein 
contains a receptor-binding domain 
(RBD), which is a variable region that is the key determinant of receptor tropism. Within the 
RBD of SARS-CoV-2 is the receptor-binding motif (RBM), a short string of residues that are 
directly responsible for binding to the host cell’s receptors (Li et al., 2005). Both SARS-CoV and 
SARS-CoV-2 utilize the human angiotensin-converting enzyme 2 (hACE2) as their receptors 
Figure 7. Wild-type SARS-CoV-2 Spike (S) protein and mutants 
 (In clockwise order: wild-type, S13I, W152, L452R) 
and pathway into a cell (Fang et al., 2005; Wuze et al., 2008) – consistent with the fact that the 
two viruses share a high sequence identity of their RBM (Hoffmann et al., 2020). However, 
SARS-CoV-2 has a 10-to-20-fold higher affinity to hACE2 compared to SARS-CoV, suggesting 
that factors other than the RBM also play a role in cell infection (Daniel et al., 2020). Once S has 
entered the cell through the hACE2 receptor, a protease located on the host cell membrane, TM 
protease serine 2 (TMPRSS2), cleaves S into the sub proteins S1 and S2. S1 is responsible for 
facilitating virion attachment to the host’s surface, while S2 carries out membrane fusion (Fehr 
& Perlman, 2015). A cleavage site at the S1/S2 boundary assists in the processing of S; SARS-
CoV-2 contains a Furin-like cleavage site (FCS), which is unique when compared to other 
HCoVs. The FCS is the result of mutations in the S gene that produce a protein containing the 
sequence 682-RRAR-685 and appears to dramatically increase SARS-CoV-2’s cell infectivity 
outside of the human respiratory tract (Xia et al., 2020). Given the ubiquity of hACE2 
throughout the body (Hamming et al., 2004), the evolution of the FCS likely played a large role 
in the improvement of SARS-CoV-2’s binding affinity and contributes to COVID-19’s systemic 
symptomatology. 
Both the S homotrimer and the presence of glycosylation sites give the virus its 
characteristic crown visual appearance. S contains between 66-87 N-linked glycosylation sites 
(Watanabe et al., 2020), and the configuration of these sites contributes to host cell tropism, 
protein folding, and stability (Watanabe et al., 2019). Additionally, glycosylation sites aid in 
facilitating immune system evasion, by shielding key epitopes from antibodies (Watanabe et al., 
2020). 
Three nonsynonymous mutations within the S gene have been correlated with increased 
deaths. Residue 13 occurs within the N-terminal signal region, which plays a role in S 
localization within the cell (Huang et al., 2020). Mutation S13I has significant effects on the 
structure of the spike, resulting in an inward folding of the β-sheets around residue 680, as well 
as the loss of an α-helix around residue 110. This results in a decrease in protein surface area, 
from the wild-type’s 5.3x104 Å2 to 4.96 x104 Å2. Previous literature has linked the S13I 
mutation, present in the epsilon variants B.1.427 and B.1.429, with a significant decrease in 
antibody binding affinity to S. This is believed to occur due to S13I inducing a shift in the NTD 
antigenic site (Matthew et al., 2021); the immune evasion induced by this shift may be 
responsible for the noted correlation with increased deaths. W152 occurs within the NTD, and 
results in the loss of the circa-residue 110 α-helix. The NTD appears to assist in the association 
between the RBD and hACE2, and is a novel target of antiviral drugs (Hamre & Procknow, 
1966); mutations in this region may strengthen the binding between the virion and its host cell 
receptor. L452R occurs within the critical RBM domain, changing the non-polar and 
hydrophobic leucine to the polar hydrophilic amino acid arginine. This specific mutation is 
present in a subset of Alpha variant (lineage B.1.1.7) isolates, which became a dominant variant 
during the 2020 winter surge (Washington et al., 2021). Our findings of a correlation between 
Figure 8. Hydrophobicity surface of SARS-CoV-2-S, zoomed on the RBD 
 (wild-type, left; L452R, right. Blue, hydrophilic; red, hydrophobic) 
L452 and increased death rates also support previous findings that the mutation improves S-
hACE2 affinity and increases S stability and replication (Motozono et al., 2021). 
As three deadly HCoVs have emerged within the last two decades, it is important to 
understand every aspect of the viruses’ mechanisms of action, evolution, and mutational 
behavior. Given the ubiquity of SARS-related viruses circulating within animal reservoirs, it is 
simply a matter of time before another spillover event occurs and a new HCoV emerges, whether 
it causes deadly diseases like SARS and MERS, or be as relatively benign as the common cold. 
Increased surveillance of known reservoirs and intermediate hosts may assist in preventing the 
next pandemic HCoV, and a complete understanding of how mutations may affect infectivity and 
mortality is necessary for the rapid identification of concerning isolates. The ongoing COVID-19 
pandemic has also given rise to variants of concern harboring multiple mutations, such as the 
recently discovered omicron variant that harbors many mutations in the S gene RBD, as well as 
mutations that may impact the FCS (Karim & Karim, 2021). Robust surveillance programs 
screening of mutations of concern, such as the mutations discussed in this paper, will aid in 
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